Steward Partners Investment Advisory’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-20
Closed -$3K 2025
2017
Q3
$3K Sell
20
-160
-89% -$22.3K ﹤0.01% 1457
2017
Q2
$18K Hold
180
﹤0.01% 905
2017
Q1
$14K Hold
180
﹤0.01% 862
2016
Q4
$8K Buy
+180
New +$8.83K ﹤0.01% 604

Steward Partners Investment Advisory's KITE Position: Q4 2017 in Review

Steward Partners Investment Advisory sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 20 shares — an estimated $3K sold.

Steward Partners Investment Advisory first reported a position in KITE in Q4 2016 and held it in 4 quarters. The position peaked at $18K in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Steward Partners Investment Advisory reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 20 Kite Pharma, Inc. shares in Q4 2017, an estimated $3K.
  • Steward Partners Investment Advisory first reported a position in Kite Pharma, Inc. in Q4 2016 and held it in 4 quarters.
  • Steward Partners Investment Advisory's Kite Pharma, Inc. position peaked at $18K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2017, filed 19 Jan 2018.